First Advantage (NYSE:FA – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.880-0.980 for the period, compared to the consensus EPS estimate of 0.920. The company issued revenue guidance of $750.0 million-$800.0 million, compared to the consensus revenue estimate of $771.7 million.
First Advantage Trading Up 0.5 %
FA opened at $18.57 on Tuesday. First Advantage has a 52 week low of $13.38 and a 52 week high of $20.75. The company has a market capitalization of $2.70 billion, a P/E ratio of 116.06 and a beta of 1.18. The stock’s fifty day moving average is $19.16 and its two-hundred day moving average is $17.59. The company has a quick ratio of 4.31, a current ratio of 4.31 and a debt-to-equity ratio of 0.61.
Analyst Ratings Changes
Several analysts have commented on FA shares. Citigroup increased their price target on shares of First Advantage from $19.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, September 25th. Truist Financial lowered their target price on shares of First Advantage from $250.00 to $249.00 and set a “buy” rating for the company in a research note on Monday, July 22nd. Finally, Wolfe Research downgraded First Advantage from an “outperform” rating to a “peer perform” rating in a research report on Thursday, October 10th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, First Advantage presently has an average rating of “Moderate Buy” and a consensus price target of $77.25.
First Advantage Company Profile
First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.
Read More
- Five stocks we like better than First Advantage
- Health Care Stocks Explained: Why You Might Want to Invest
- Lam Research Fueled by Unyielding AI Demand Growth
- CD Calculator: Certificate of Deposit Calculator
- Generac: 5 Reasons to Buy This Stock Before Year’s End
- Dividend Capture Strategy: What You Need to Know
- Top 2 CRM Stocks Positioned to Surge Higher With AI in 2025
Receive News & Ratings for First Advantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Advantage and related companies with MarketBeat.com's FREE daily email newsletter.